Prunella Blinman COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Preferences for adjuvant sorafenib after resection of intermediate to high risk renal cell carcinoma of the kidney — COSA - Minding your P's and Q's: Psychosocial aspects of urologic cancer